Mats Persson

Mats Persson has over 35 years of experience in marketing and licensing within the global pharmaceutical industry. Persson held the position as Head of Nordic at Tesaro, an American biotech company in oncology, recently acquired by GSK, until December 2018. He has extensive experience from senior positions at Astellas Pharma Norden/Baltic (CEO), Novo Nordisk, Pharmacia Corporation and Ferring International.